Medivation now listing on Amex

The American Stock Exchange yesterday began listing the common stock of Medivation (San Francisco), under the ticker symbol MDV.

Medivation describes its activities as acquiring promising medical device and pharmaceutical technologies in the late preclinical development phase, develops those technologies through human first proof-of-efficacy studies and seeks to sell or partner successful programs with larger biotech, medical device and pharmaceutical companies for late-stage clinical studies and commercialization.

David Hung, MD, company president and CEO, said, “Based on recent discussions with investors, we believe that an exchange listing may provide Medivation a number of benefits, including increased visibility in the financial community, greater liquidity for our stock and a larger potential investor base.“

No Comments